151 related articles for article (PubMed ID: 9484846)
21. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
22. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract][Full Text] [Related]
23. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a I-cM region of common allelic loss.
Kimura M; Abe T; Sunamura M; Matsuno S; Horii A
Genes Chromosomes Cancer; 1996 Oct; 17(2):88-93. PubMed ID: 8913725
[TBL] [Abstract][Full Text] [Related]
24. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
25. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
Bell DW; Jhanwar SC; Testa JR
Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
[TBL] [Abstract][Full Text] [Related]
26. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.
Rodabaugh KJ; Biggs RB; Qureshi JA; Barrett AJ; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1995 Oct; 11(7):1249-54. PubMed ID: 7478544
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
28. Allelotype of human ovarian cancer.
Sato T; Saito H; Morita R; Koi S; Lee JH; Nakamura Y
Cancer Res; 1991 Oct; 51(19):5118-22. PubMed ID: 1655245
[TBL] [Abstract][Full Text] [Related]
29. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.
Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM
Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366
[TBL] [Abstract][Full Text] [Related]
30. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
31. [Allelic losses of tumor suppressor gene on chromosome 17 in ovarian cancer].
Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Sonoda T; Ueda K; Obi S; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):457-63. PubMed ID: 8496636
[TBL] [Abstract][Full Text] [Related]
32. Parkin gene alterations in ovarian carcinoma from northern Indian population.
Mehdi SJ; Ali A; Rizvi MM
Pathol Oncol Res; 2011 Sep; 17(3):579-86. PubMed ID: 21221875
[TBL] [Abstract][Full Text] [Related]
33. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
34. Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.
Abdollahi A; Roberts D; Godwin AK; Schultz DC; Sonoda G; Testa JR; Hamilton TC
Oncogene; 1997 Apr; 14(16):1973-9. PubMed ID: 9150364
[TBL] [Abstract][Full Text] [Related]
35. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
Gabra H; Watson JE; Taylor KJ; Mackay J; Leonard RC; Steel CM; Porteous DJ; Smyth JF
Cancer Res; 1996 Mar; 56(5):950-4. PubMed ID: 8640783
[TBL] [Abstract][Full Text] [Related]
36. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
Chen T; Sahin A; Aldaz CM
Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
[TBL] [Abstract][Full Text] [Related]
37. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
Arlt MF; Herzog TJ; Mutch DG; Goodfellow PJ
Gynecol Oncol; 1996 Feb; 60(2):308-12. PubMed ID: 8631557
[TBL] [Abstract][Full Text] [Related]
39. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
[TBL] [Abstract][Full Text] [Related]
40. Novel suppressor loci on chromosome 14q in primary bladder cancer.
Chang WY; Cairns P; Schoenberg MP; Polascik TJ; Sidransky D
Cancer Res; 1995 Aug; 55(15):3246-9. PubMed ID: 7614456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]